The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 5, 1996, Pages 13-16

  Hori, Osamu ^a   Yan, Shi Du ^a   Ogawa, Satoshi ^b   Kuwabara, Keisuke ^b   Matsumoto, Masayasu ^b   Stern, David ^a   Schmidt, Ann Marie ^a  

^a College of Physician and Surgeons ^*  (United States)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Diabetes mellitus; Glycation; Mononuclear phagocytes; Oxidative stress; Receptors; Vascular disease

Indexed keywords

CELL SURFACE RECEPTOR; HEME; LIPID; PROTEIN; SUGAR; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD VESSEL WALL; CONFERENCE PAPER; DIABETES MELLITUS; ENDOTHELIUM CELL; GLYCATION; HYPERGLYCEMIA; MESANGIUM CELL; MONOCYTE; MOUSE; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR DISEASE;

EID: 0030513682     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp5.13     Document Type: Conference Paper

References (26)

1. Ruderman N, Williamson J, Brownlee M. Glucose and diabetic vascular disease. FASEB J 1992; 6: 2905-2914
2. Baynes J. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412
3. Sell D, Monnier V. Structure elucidation of senescence cross-link from human extracellular matrix: implication of pentoses in the aging process. J Biol Chem 1989; 264: 21597-21602
4. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end-products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-1320
5. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 1993; 90: 6434-6438
6. Hicks M, Delbridge L, Yue D, Reeve R. Catalysis of lipid peroxidation by glucose and glycosylated proteins. Biochem Biophys Res Commun 1988; 151: 649-655
7. Hunt J, Smith C, Wolff S. Autooxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 1990; 30: 1420-1424
8. 2-Microglobulin modified with advanced glycation end-products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993; 92: 1243-1252
9. Yan SD Chen X, Schmidt AM et al. The presence of glycated tau in Alzheimer's disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 1994; 91: 7787-7791
10. Mullarkey C, Edelstein D, Brownlee M. Free radical generation by early glycation end-products: a mechanism for accelerated atherogenesis in diabetes, Biochem Biophys Res Commun 1990; 173: 932-939
11. Sakurai T, Tsuchiya S. Superoxide production from nonenzymatically glycated protein. FEBS Lett 1988; 236: 406-410
12. Schmidt AM, Vianna M, Gerlach M et al. Isolation and characterization of binding proteins for advanced glycation end-products from lung tissue which are present on the endothelial cell surface. J Biol Chem 1992; 267: 14987-14997
13. Yang Z, Makita J, Horii, Y et al. Two novel rat liver membrane proteins that bind advanced glycosylation end products: relationship to macrophage receptor for glucose-modified proteins. J Exp Med 1991; 174: 515-524
14. Khoury J, Thomas C, Loike J, Hickman S, Cao L, Silverstein S. Macrophages adhere to glucose-modified basement membranes via their scavenger receptors. J Biol Chem 1994; 269: 10197-10200
15. Schmidt AM, Yan SD, Brett J et al. Regulation of human mononuclear phagocyte migration by cell surface binding proteins for advanced glycation end products. J Clin Invest 1993; 92: 2155-2168
16. 2-microglobulin modified with advanced glycation end-products in the pathogenesis of hemodialysis-associated amyloidosis. J Clin Invest 1994; 93: 521-528
17. 2-microglobulin modified by glycation is RAGE. Circulation 1994; 90: 1-233 (#1251]
18. Yan SD, Schmidt AM, Anderson GM et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end-products with their receptors/binding proteins. J Biol Chem 1994; 269: 9889-9897
19. Schmidt AM, Hori O, Chen JX et al. Advanced glycation end-products interacting with their endothelial receptor induce expression of Vascular Cell Adhesion Molecule-1 (VCAM-1] in cultured human endothelial cells and in mice. J Clin Invest 1995; 96: 1395-1403
20. Collins T. Endothelial nuclear factor kB and the initiation of the atherosclerotic lesion. Lab Invest 1993; 10: 336-349
21. Cybulsky M, Gimbrone M. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991; 251: 788-791
22. Li H, Cybulsky M, Gimbrone M, Libby P. An atherogenic diet rapidly induces VCAM-1: a cytokine-regulatable mononuclear leukocyte adhesion molecule in rabbit aortic endothelium. Arterioscler Thromb 1993; 13: 197-204
23. Richardson M, Hadcock S, DeReske, Cybulsky M. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler Thromb 1994; 14: 760-769
24. O'Brien DK, Allen MD, McDonald TO et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993; 92: 945-951
25. Marui, N, Offerman M, Swerlick R et al. VCAM-1 gene transcription and expression are regulated through an oxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92: 1866-1984.
26. Schmidt AM, Hasu M, Popov D et al. The receptor for advanced glycation end-products (AGEs) has a central role in vessel wall interaction and gene activation in response to AGEs in the intravascular space. Proc Natl Acad Sci USA 1994; 91: 8807-8811